AMGN vs GENK · P/E 24, rev $10.05B vs rev $212.5M
Amgen Inc (AMGN) versus GEN Restaurant Group, Inc. Class A Common Stock (GENK) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
GEN Restaurant Group, Inc. Class A Common Stock (GENK) is a restaurants company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported GENK revenue for 2025-12-31 was $212.5M. Net income was -$3.0M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. GENK currently screens at market cap $63.6M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. GENK currently screens at market cap $63.6M.
Not investment advice. Open the AMGN and GENK stock pages for the full models.
Not investment advice.